SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022971
Filing Date
2020-05-07
Accepted
2020-05-07 16:51:28
Documents
72
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20200331.htm 10-Q 1813997
2 EX-10.2 sndx-ex102_933.htm EX-10.2 327759
3 EX-10.3 sndx-ex103_505.htm EX-10.3 8798
4 EX-10.4 sndx-ex104_396.htm EX-10.4 188189
5 EX-10.5 sndx-ex105_395.htm EX-10.5 212515
6 EX-10.6 sndx-ex106_394.htm EX-10.6 180078
7 EX-10.7 sndx-ex107_393.htm EX-10.7 175059
8 EX-31.1 sndx-ex311_8.htm EX-31.1 10273
9 EX-31.2 sndx-ex312_6.htm EX-31.2 10726
10 EX-32.1 sndx-ex321_7.htm EX-32.1 11869
11 GRAPHIC gsqqs0r5eskc000001.jpg GRAPHIC 651
  Complete submission text file 0001564590-20-022971.txt   8097293

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT sndx-20200331.xml EX-101.INS 1582535
13 XBRL TAXONOMY EXTENSION SCHEMA sndx-20200331.xsd EX-101.SCH 57666
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20200331_cal.xml EX-101.CAL 46807
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20200331_def.xml EX-101.DEF 194102
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20200331_lab.xml EX-101.LAB 410159
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20200331_pre.xml EX-101.PRE 310973
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 20857286
SIC: 2834 Pharmaceutical Preparations